Baker Brothers Life Sciences LP — Form D

Baker Brothers Life Sciences LP of NEW YORK, NY, a pooled investment fund, filed a Form D exempt-offering notice with the SEC on 2025-10-14. Industry: Pooled Investment Fund.

Offering

Filed: 2025-10-14
Form: D
Accession: 0001104659-25-099348
Industry: Pooled Investment Fund
Exemptions: 06b, 3C, 3C.7
Security types: fund interests
SEC file number: 021-560745

Issuer

Name: Baker Brothers Life Sciences LP
CIK: 0001363364
Entity type: Limited Partnership
Jurisdiction: DELAWARE
Address: 860 WASHINGTON STREET THIRD FLOOR, NEW YORK, NY, 10014
Phone: 212-339-5600

Officers, directors & promoters (10)

Name	Role	Location
Felix Baker	Executive Officer	New York, NY
Julian Baker	Executive Officer	New York, NY
n/a Baker Brothers Life Sciences Capital (GP), LLC	Executive Officer	NEW YORK, NY
n/a Baker Brothers Life Sciences Capital, L.P.	Executive Officer	NEW YORK, NY
Felix Baker	Related Person	New York, NY
Julian Baker	Related Person	New York, NY
General Partner Baker Brothers Life Sciences Capital, L.P.	Executive Officer	NEW YORK, NY
General Partner Baker Brothers Life Sciences Capital, L.P.	Promoter	NEW YORK, NY
General Partner of the General Partner Baker Brothers Life Sciences Capital (GP), LLC	Promoter	NEW YORK, NY
Baker Brothers Life Sciences Capital, L.P.	Executive Officer	New York, NY

Other filings by this issuer (12)

Filed	Form	Offering	Sold
2026-07-01	D	—	—
2024-08-12	D/A	—	$3.3B
2023-07-14	D	—	—
2022-07-01	D	—	—
2020-07-01	D	—	—
2018-07-02	D	—	—
2016-07-12	D	—	—
2016-02-17	D	—	—
2014-08-13	D	—	$37.0M
2013-11-14	D	—	$530.0M
2012-05-15	D	—	$554.6M
2010-12-30	D	$500.0M	—

More